Fortress Biotech logo
Fortress Biotech FBIO
$ 1.59 0.96%

Квартальный отчет 2024-Q3
добавлен 14.11.2024

report update icon

Fortress Biotech Мультипликаторы 2011-2024 | FBIO

Мультипликаторы по годам Fortress Biotech

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-0.3 -0.1 -2.6 -4.9 -3.2 -0.8 -2.5 -1.7 -2.4 -4.5 -2.2 -5.8 -1.3

P/S

0.2 0.1 2.5 5.0 3.5 2.4 0.9 5.7 135.5 - - - -

EPS

-8.5 -16.0 -0.8 -0.7 -0.7 -1.9 -1.6 -1.4 -1.2 -0.6 -1.2 -1.3 -5.5

EV (Enterprise Value)

101 млн 70.7 млн 35.6 млн 128 млн 147 млн 120 млн 179 млн 93.4 млн 53.1 млн 59.9 млн 2.25 млн 138 млн 29.9 млн

EBITDA per Share

-17.3 -33.8 -2.28 -1.24 -1.94 -2.71 -2.38 -1.63 -1.07 -0.568 -1.18 -1.25 -4.39

EV/EBITDA

-0.2 -0.6 -0.8 -0.7 -1.2 -0.5 -0.8 -2.7 0.1 -4.9 -0.8

PEG

-0.0 -0.0 -0.17 -0.45 -0.05 0.04 0.15 0.05 0.03 -0.08 -0.56 -0.07 0.01

P/B

10.2 0.1 0.8 1.2 1.8 3.3 1.4 1.1 1.4 1.3 1.0 7.2 2.6

P/CF

-0.1 -0.0 -1.5 -2.5 -1.2 -0.6 -1.8 -1.7 -3.6 -5.6 -2.8 -6.8 -3.3

ROE %

-268.97 -207.51 -59.54 -23.62 -55.09 -426.21 -55.50 -66.41 -57.47 -28.91 -45.72 -125.31 -190.05

ROA %

-36.20 -29.42 -16.32 -14.15 -17.65 -59.68 -27.19 -32.27 -40.83 -22.82 -36.94 -67.35 -155.55

ROCE %

-631.40 -487.92 -173.49 -33.56 -61.29 -140.55 -56.69 -57.56 -46.77 -24.22 -40.03 -75.78 -176.26

Current Ratio

1.0 1.2 2.3 5.5 3.4 2.0 2.7 1.9 9.4 17.3 8.9 7.9 6.7

DSO

93.8 123.7 112.6 160.8 143.5 103.1 33.8 192.4 - - - - -

DIO

166.8 142.4 64.1 35.1 29.7 40.4 0.4 6.5 - - - - -

DPO

630.2 620.7 269.8 1017.3 1228.6 2039.0 82.3 781.4 - - - - -

Операционный цикл

260.6 266.1 176.7 196.0 173.2 143.5 34.2 199.0 - - - - -

Финансовый цикл

-369.6 -354.6 -93.0 -821.3 -1055.4 -1895.5 -48.1 -582.4 - - - - -

Все данные представлены в валюте USD

Мультипликаторы поквартально Fortress Biotech

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.76 -0.73 -1.03 - -0.94 -3.65 -3.47 - -4.11 -0.26 -0.18 - -0.26 -0.04 -0.11 - -0.2 -0.19 -0.19 - -0.22 -0.24 0.03 -0.55 -0.37 -0.5 -0.49 -0.25 -0.67 -0.43 -0.3 -0.43 -0.32 -0.31 -0.31 -0.3 -0.46 -0.16 -0.31 -0.1 -0.13 -0.13 -0.21 -0.27 -0.24 -0.38 -0.35 -0.36 -0.24 -0.34 -0.35 -0.52 -0.48 -0.64 -4.71

EBITDA per Share

-1.12 -1.5 -2.11 - -1.78 -6.68 -8.54 - -8.38 -0.56 -0.54 - -0.61 -0.52 -0.36 - -0.29 -0.36 -0.33 - -0.39 -0.46 -0.66 -0.71 -0.62 -0.58 -0.8 -0.6 -0.78 -0.62 -0.46 -0.65 -0.42 -0.43 -0.39 -0.27 -0.46 -0.2 -0.33 -0.11 -0.12 -0.13 -0.18 -0.24 -0.23 -0.37 -0.34 -0.34 -0.24 -0.34 -0.35 -0.28 -0.5 -0.64 -1.21

ROE %

-150.92 -52.01 164.64 84.76 62.55 2.24 -167.62 -44.81 -54.59 -42.16 -29.13 -19.53 -35.03 -40.74 -52.59 -41.09 -89.77 -122.96 -159.66 -93.34 -1436.75 -2286.45 -3403.38 -4543.57 -3219.97 -2373.17 -1239.30 -127.21 -152.68 -134.82 -134.21 -143.12 -119.01 -117.24 -95.69 -85.19 -69.28 -43.85 -39.66 -28.91 -35.70 -38.82 -45.27 -45.72 -72.99 -90.29 -106.46 -125.31 -121.11 -111.76 -101.97 -190.05 -17.59 -19.51 -117.83

ROA %

-30.35 -23.58 -29.78 -25.23 -32.19 -35.80 -27.95 -16.69 -21.78 -19.92 -14.90 -8.20 -12.86 -12.43 -15.58 -12.42 -18.05 -19.03 -20.82 -10.81 -28.45 -34.62 -44.16 -59.68 -46.27 -45.49 -37.23 -27.19 -33.17 -29.74 -29.99 -32.27 -32.21 -39.92 -37.81 -40.83 -34.84 -24.67 -24.74 -22.82 -28.41 -31.05 -36.39 -36.94 -48.34 -55.03 -60.17 -67.35 -74.96 -74.88 -75.10 -155.55 -14.40 -15.97 -96.44

ROCE %

- - - - -50.06 -100.11 -134.59 -108.96 -132.45 -105.89 -88.67 -69.10 -92.07 -91.53 -99.59 -69.73 -155.71 -218.73 -289.89 -306.84 -2532.16 -3969.13 -5244.04 -6964.79 -4797.72 -3335.25 -2012.37 -203.60 -229.05 -213.19 -208.97 -213.04 -152.15 -139.36 -108.74 -90.41 -74.64 -48.86 -41.86 -29.08 -33.61 -36.78 -42.63 -43.70 -69.80 -87.04 -103.88 -123.34 -113.02 -105.01 -95.20 -183.17 -18.46 -19.53 -117.84

Current Ratio

0.9 0.9 1.0 1.0 0.9 0.9 1.1 1.2 1.5 1.7 1.9 2.3 2.1 2.5 2.7 2.4 2.4 2.4 2.5 1.5 1.5 1.5 1.5 1.2 1.2 1.2 1.2 2.0 2.0 2.0 2.0 1.9 1.9 1.9 1.9 3.5 3.5 3.5 3.5 4.8 4.8 4.8 4.8 5.2 5.2 5.2 5.2 2.2 2.2 2.2 2.2 5.5 5.5 5.5 5.5

DSO

65.9 62.1 87.6 - 32.5 116.4 204.9 - 157.9 144.6 103.5 - 125.3 116.7 170.8 - 230.4 208.8 116.2 - 126.4 133.6 134.1 55.8 97.0 73.6 102.5 13.1 12.6 14.0 8.0 17.3 338.3 74.9 126.5 - - - - - - - - - - - - - - - - - - - -

DIO

185.4 141.4 139.1 - 164.6 149.5 194.1 - 197.7 192.4 144.6 - 105.9 101.2 43.1 - 37.9 41.0 27.1 - 28.9 32.8 37.2 - 44.0 - 26.3 - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

621.5 556.3 512.8 - 662.2 672.3 871.0 - 693.1 588.6 511.5 - 232.8 87.0 133.2 - 308.2 166.7 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Операционный цикл

251.3 203.4 226.8 - 197.0 265.9 399.0 - 355.6 337.0 248.2 - 231.3 217.9 213.9 - 268.4 249.8 143.2 - 155.4 166.3 171.3 55.8 141.0 73.6 128.8 13.1 12.6 14.0 8.0 17.3 338.3 74.9 126.5 - - - - - - - - - - - - - - - - - - - -

Финансовый цикл

-370.1 -352.9 -286.1 - -465.2 -406.5 -472.0 - -337.6 -251.6 -263.3 - -1.5 130.9 80.7 - -39.8 83.1 143.2 - 155.4 166.3 171.3 55.8 141.0 73.6 128.8 13.1 12.6 14.0 8.0 17.3 338.3 74.9 126.5 - - - - - - - - - - - - - - - - - - - -

Все данные представлены в валюте USD